Charles River sells CDMO QS Pharma to Quotient Clinical by Eric Palmer Thursday, February 16, 2017 Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.
